company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,66182000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,193012000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,6358000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6021000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1937000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,273510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18554000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,138907000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,535000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,8674000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,148116000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,,totalassets,Total Assets,=,debit,usd,440180000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,10398000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,7425000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,83938000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,272000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,102033000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,172501000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,168000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,172669000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,274702000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,490979000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-326787000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1286000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,165478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,165478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,165478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q2,,2010-06-30,2010-08-05 16:53:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,440180000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,46881000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,184486000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4881000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6432000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,1943000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,244623000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18399000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,140523000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,491000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,8570000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,149584000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,,totalassets,Total Assets,=,debit,usd,412606000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6561000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,10880000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,81755000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,237000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,99433000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,152530000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,152530000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,251963000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,495772000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-336417000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1288000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,160643000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,160643000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,160643000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2010.0,Q3,,2010-09-30,2010-11-04 17:27:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,412606000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90590000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,154050000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1150000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4919000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,250709000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,17021000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,100917000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,405000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,101322000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,,totalassets,Total Assets,=,debit,usd,369052000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5800000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12050000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,81494000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,99344000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,123074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1067000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,124141000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,223485000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,505217000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-359632000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-18000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,145567000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,145567000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,145567000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q1,,2011-03-31,2011-05-05 08:00:27+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,369052000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,67110000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,150839000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1308000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5077000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,224334000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16252000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,99881000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,361000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,100242000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,,totalassets,Total Assets,=,debit,usd,340828000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,7949000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,11380000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,81205000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,100534000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,103001000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,742000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,103743000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,204277000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,510253000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-373456000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-246000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,136551000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,136551000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,136551000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q2,,2011-06-30,2011-08-03 08:30:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,340828000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,74336000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,98685000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2027000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4909000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,179957000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15309000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,114639000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,318000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,114957000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,,totalassets,Total Assets,=,debit,usd,310223000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5486000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,12230000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,76211000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,93927000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,87694000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,729000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,88423000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,182350000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,514717000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-386693000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-151000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,127873000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,127873000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,127873000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2011.0,Q3,,2011-09-30,2011-11-03 16:58:25+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,310223000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,61739000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,137356000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2192000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,7252000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,208539000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,13703000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,117822000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,231000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,118053000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,,totalassets,Total Assets,=,debit,usd,340295000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4339000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,13006000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,49018000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,275000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,66638000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,75576000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,703000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,76279000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,142917000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,609779000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-412364000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-37000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,197378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,197378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,197378000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q1,,2012-03-31,2012-05-03 17:01:04+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,340295000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,48274000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,180750000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,4385000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,6933000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,240342000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,14206000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,63741000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,188000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,63929000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,,totalassets,Total Assets,=,debit,usd,318477000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5519000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14228000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,35953000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,1364000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57064000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,72436000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,690000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,73126000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,130190000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,613669000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-425320000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-62000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,188287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,188287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,188287000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q2,,2012-06-30,2012-08-08 17:00:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,318477000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,75838000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,152498000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,1918000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,5679000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,235933000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18792000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,67482000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,145000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,67627000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,,totalassets,Total Assets,=,debit,usd,322352000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5093000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14914000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,31996000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,2755000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54758000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,89913000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,521000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,90434000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,145192000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,621874000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-444822000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,108000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,177160000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,177160000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,177160000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2012.0,Q3,,2012-09-30,2012-11-05 17:15:52+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,322352000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,97804000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,138207000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,558000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,3542000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,240111000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18983000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,212484000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,212484000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,,totalassets,Total Assets,=,debit,usd,471578000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,3105000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,9086000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,34536000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,3023000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,49750000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,110272000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,110272000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,160022000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,806758000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-516023000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,20821000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,311556000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,311556000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,311556000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q1,,2013-03-31,2013-05-07 17:00:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,471578000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,24975000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,184719000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,460000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4205000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,214359000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18045000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,230154000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,230154000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,,totalassets,Total Assets,=,debit,usd,462558000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,4534000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,8488000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,34812000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,5232000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53066000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,101317000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,101317000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,154383000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,814237000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-534192000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,28130000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,308175000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,308175000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,308175000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q2,,2013-06-30,2013-08-09 08:08:43+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,462558000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,11840000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,181939000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,609000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,4776000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,199164000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16974000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,231365000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,231365000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,,totalassets,Total Assets,=,debit,usd,447503000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,2728000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15386000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,34758000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,2023000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,54895000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,95026000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,95026000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,149921000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,834292000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-563878000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,27168000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,297582000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,297582000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,297582000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2013.0,Q3,,2013-09-30,2013-11-07 08:18:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,447503000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,350589000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,314901000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,164000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,8409000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,674063000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,15731000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,390503000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,390503000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,,totalassets,Total Assets,=,debit,usd,1080297000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5037000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,41979000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,29990000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,6825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,83831000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,40493000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,41493000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,125324000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1777121000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-847178000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25030000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,954973000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,954973000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,954973000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q1,,2014-03-31,2014-05-09 16:35:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1080297000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,80727000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,574035000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,89000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10270000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,665121000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,16953000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,350585000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,350585000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,,totalassets,Total Assets,=,debit,usd,1032659000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,6168000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,15783000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,27713000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,4081000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,53745000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,35645000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,36645000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,90390000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1811538000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-891252000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,21983000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,942269000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,942269000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,942269000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q2,,2014-06-30,2014-08-08 08:37:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1032659000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,82721000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,549213000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,384000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,10699000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,643017000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,18806000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,324534000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,324534000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,,totalassets,Total Assets,=,debit,usd,986357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,5201000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,19799000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,30993000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,856000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,56849000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,24530000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,500000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,25030000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,81879000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1824533000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-935241000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,15186000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,904478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,904478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,904478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2014.0,Q3,,2014-09-30,2014-11-06 08:30:58+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,986357000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,306580000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,760293000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,10107000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,13206000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1090186000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,21166000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,483771000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,33667000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,517438000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,,totalassets,Total Assets,=,debit,usd,1628790000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15486000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,14427000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,15109000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,33667000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcurrentliabilities,othertaxespayable,Other Taxes Payable,+,credit,usd,2004000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,80693000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,51587000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,51587000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,132280000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2451532000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1007407000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,52385000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1496510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1496510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1496510000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q1,,2015-03-31,2015-05-08 08:13:54+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1628790000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,151262000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,853368000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9403000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,15117000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1029150000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,25169000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,456798000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,19654000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,476452000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,,totalassets,Total Assets,=,debit,usd,1530771000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,15715000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,17758000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,13471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,19654000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,66598000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,55569000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,55569000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,122167000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2469032000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1079190000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,18762000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1408604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1408604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1408604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q2,,2015-06-30,2015-08-07 07:58:28+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1530771000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,149218000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,866992000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8130000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,17453000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1041793000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,26316000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,358629000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,9406000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,368035000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,,totalassets,Total Assets,=,debit,usd,1436144000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,14272000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,18444000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,14990000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcurrentliabilities,currentdeferredtaxliabilities,Current Deferred & Payable Income Tax Liabilities,+,credit,usd,9406000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,57112000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,57428000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,57428000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,114540000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2484805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1155982000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-7219000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1321604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1321604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1321604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2015.0,Q3,,2015-09-30,2015-11-09 07:44:31+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1436144000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,231278000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,782356000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,8814000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,27626000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1050074000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,36814000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,228590000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,230061000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,,totalassets,Total Assets,=,debit,usd,1316949000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,17442000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,30805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,18122000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,66369000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,60156000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1373000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,61529000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,127898000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2547739000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1349677000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-9011000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1189051000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1189051000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1189051000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q1,,2016-03-31,2016-05-04 16:46:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1316949000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,271076000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,585326000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,9514000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22152000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,888068000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,55394000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,437229000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,438700000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,,totalassets,Total Assets,=,debit,usd,1382162000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,12824000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,37551000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,20200000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,70575000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,61328000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1777000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,213105000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,283680000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2566584000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1439806000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-28296000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1098482000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1098482000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1098482000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q2,,2016-06-30,2016-08-04 16:47:03+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1382162000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,168481000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,544655000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15146000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,19282000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,747564000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,74219000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,489566000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1561000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,491127000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,,totalassets,Total Assets,=,debit,usd,1312910000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,23137000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,36211000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,22413000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,81761000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,64190000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,1991000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,216181000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,297942000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2586623000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1543877000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-27778000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1014968000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1014968000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1014968000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2016.0,Q3,,2016-09-30,2016-11-03 16:03:01+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1312910000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,171079000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,388525000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,19457000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,18127000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,597188000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,129962000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,405305000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,406776000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,,totalassets,Total Assets,=,debit,usd,1133926000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,25371000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,31842000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38573000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,95786000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,54055000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,3184000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,207239000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,303025000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2628830000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1764101000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-33828000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,830901000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,830901000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,830901000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q1,,2017-03-31,2017-05-05 08:36:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1133926000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,408671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,514600000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,15405000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,22033000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,960709000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,147533000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,324570000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,326041000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,,totalassets,Total Assets,=,debit,usd,1434283000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,23170000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,43820000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,41736000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,108726000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,49776000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2815000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,202591000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,311317000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3039446000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1882521000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-33959000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1122966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1122966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1122966000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q2,,2017-06-30,2017-08-09 16:31:38+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1434283000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,202045000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,746249000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,14644000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,30430000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,993368000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,161899000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,201543000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,1471000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,203014000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,,totalassets,Total Assets,=,debit,usd,1358281000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,9239000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,51260000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,40546000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,101045000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,150000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,45559000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,2842000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,198401000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,299446000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3098034000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2005458000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-33741000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1058835000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1058835000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1058835000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2017.0,Q3,,2017-09-30,2017-11-07 16:31:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1358281000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,396149000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1171715000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,50768000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,66665000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1685297000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,201979000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,30648000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,5215000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,35863000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,,totalassets,Total Assets,=,debit,usd,1923139000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,13206000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,63824000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,38353000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,115383000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,18493000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4458000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,52951000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,168334000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4010347000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2220689000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-34853000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1754805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1754805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1754805000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q1,,2018-03-31,2018-05-04 17:04:02+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1923139000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,361457000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,1086209000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,2961000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,51932000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1502559000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,227839000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14166000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,58991000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,,totalassets,Total Assets,=,debit,usd,1789389000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,11988000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,89867000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,11804000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,113659000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,20742000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4186000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,54928000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,168587000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4038858000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2384249000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-33807000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1620802000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1620802000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1620802000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q2,,2018-06-30,2018-08-02 08:46:32+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1789389000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,316608000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,920226000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,3362000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,11081000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,90843000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1342120000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,272652000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,16057000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,60882000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,,totalassets,Total Assets,=,debit,usd,1675654000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,21772000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,93564000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,6167000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,121503000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,41697000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,4335000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,76032000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,197535000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4141042000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-2629531000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-33392000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1478119000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1478119000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1478119000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2018.0,Q3,,2018-09-30,2018-11-07 16:32:10+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1675654000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,724959000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,519578000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,33801000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,32001000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,81674000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1392013000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,341712000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,235449000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,280274000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,,totalassets,Total Assets,=,debit,usd,2013999000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,22671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,106873000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,2642000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,16977000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,149163000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,478000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,287372000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,317850000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,467013000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4602726000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3022887000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-32853000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1546986000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1546986000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1546986000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q1,,2019-03-31,2019-05-02 16:31:34+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2013999000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,1136289000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,790542000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,30739000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,40587000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,65616000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2063773000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,371769000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,44825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,236044000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,280869000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,,totalassets,Total Assets,=,debit,usd,2716411000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,71215000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,138800000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,89242000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,29347000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,328604000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,30000000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,313887000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,286725000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,630612000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,959216000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5035394000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3242368000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-35831000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1757195000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1757195000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1757195000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q2,,2019-06-30,2019-08-06 16:19:23+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2716411000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,923304000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,797754000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,48109000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,54562000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentassets,prepaidexpenses,Prepaid Expenses,+,debit,usd,73536000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1897265000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,396456000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,14825000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,233076000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,247901000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,,totalassets,Total Assets,=,debit,usd,2541622000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,39392000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentliabilities,accruedexpenses,Accrued Expenses,+,credit,usd,177948000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,107359000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcurrentliabilities,othercurrentliabilities,Other Current Liabilities,+,credit,usd,28165000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,352864000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalnoncurrentliabilities,noncurrentdeferredrevenue,Noncurrent Deferred Revenue,+,credit,usd,296179000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,285492000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,581671000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,934535000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalliabilitiesandequity,commitmentsandcontingencies,Commitments & Contingencies,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalequity,totalpreferredequity,Preferred Stock,+,credit,usd,0.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,5092361000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-3450903000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-34371000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1607087000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1607087000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1607087000.0
Alnylam Pharmaceuticals Inc,ALNY,,0001178670,2019.0,Q3,,2019-09-30,2019-10-31 16:03:40+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2541622000.0
